The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
Links for upcoming talks and recordings for previous talks are available on the Discovery Series feed and information on continuing education is available below.
For questions about the Discovery Series or if you have suggestions for precision health topics to cover at a future session, please reach out to Mary Hindle at email@example.com.
Continuing Professional Education Credit
Up to 1.0 contact hour will be awarded to all participants who view the live sessions in their entirety and complete the evaluation form.
University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Midwest Multistate Division Provider Number MO1022-6
The Office of Continuing Education, School of Medicine, University of Missouri is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Office of Continuing Education, School of Medicine, University of Missouri designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
CONFLICT OF INTEREST: All persons with influence over the content of this program have been asked to disclose relevant financial interests, in the past 12 months, that might have an impact. John Spertus, MD, a planning committee member, is a consultant for Jannsen, Bayer, Myokardia, Merck and Novartis, and receives research support from Abbott Vascular.
No other speaker or planning committee member has a relevant financial interest.